Viva Extends Hong Kong Biotech Fever in City's Hottest 2019 IPO

Bookmark
(Bloomberg) -- Viva Biotech Holdings bucked a decline across Asia on its trading debut following Hong Kong’s most popular initial public offering this year.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.